Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 10971 entries
Sorted by: Best Match Show Resources per page
[Fatal liver cell necrosis following administration of glafenine].

Nederlands tijdschrift voor geneeskunde

Koek GH, Stricker BH, Veldhuizen RW, de Graaf P.
PMID: 1677166
Ned Tijdschr Geneeskd. 1991 Jun 15;135(24):1088-90.

The case is described of a patient with fulminant hepatic failure attributed to intake of glafenine 400 mg daily for 15 days. The first symptoms appeared two weeks after discontinuation of glafenine. Other causes of hepatic necrosis could be...

Cite
Koek GH, Stricker BH, Veldhuizen RW, et al. Dodelijk verlopende levercelnecrose na gebruik van glafenine. [Fatal liver cell necrosis following administration of glafenine]. Ned Tijdschr Geneeskd. 1991;135(24):1088-90
Koek, G. H., Stricker, B. H., Veldhuizen, R. W., & de Graaf, P. (1991). Dodelijk verlopende levercelnecrose na gebruik van glafenine. [Fatal liver cell necrosis following administration of glafenine]. Nederlands tijdschrift voor geneeskunde, 135(24), 1088-90.
Koek, G H, et al. "Dodelijk verlopende levercelnecrose na gebruik van glafenine." [Fatal liver cell necrosis following administration of glafenine]. Nederlands tijdschrift voor geneeskunde vol. 135,24 (1991): 1088-90.
Koek GH, Stricker BH, Veldhuizen RW, de Graaf P. Dodelijk verlopende levercelnecrose na gebruik van glafenine. [Fatal liver cell necrosis following administration of glafenine]. Ned Tijdschr Geneeskd. 1991 Jun 15;135(24):1088-90. Dutch. PMID: 1677166.
Copy Download .nbib Format: NLM
Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice.

Biochemical pharmacology

Safayhi H, Mack T, Ammon HP.
PMID: 2018558
Biochem Pharmacol. 1991 May 15;41(10):1536-7. doi: 10.1016/0006-2952(91)90575-p.

No abstract available.

Cite
Safayhi H, Mack T, Ammon HP. Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol. 1991;41(10):1536-7doi: 10.1016/0006-2952(91)90575-p.
Safayhi, H., Mack, T., & Ammon, H. P. (1991). Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice. Biochemical pharmacology, 41(10), 1536-7. https://doi.org/10.1016/0006-2952(91)90575-p
Safayhi, H, et al. "Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice." Biochemical pharmacology vol. 41,10 (1991): 1536-7. doi: https://doi.org/10.1016/0006-2952(91)90575-p
Safayhi H, Mack T, Ammon HP. Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol. 1991 May 15;41(10):1536-7. doi: 10.1016/0006-2952(91)90575-p. PMID: 2018558.
Copy Download .nbib Format: NLM
Lovastatin-induced hepatitis.

Israel journal of medical sciences

Raveh D, Arnon R, Israeli A, Eisenberg S.
PMID: 1559791
Isr J Med Sci. 1992 Feb;28(2):101-2.

No abstract available.

Cite
Raveh D, Arnon R, Israeli A, et al. Lovastatin-induced hepatitis. Isr J Med Sci. 1992;28(2):101-2
Raveh, D., Arnon, R., Israeli, A., & Eisenberg, S. (1992). Lovastatin-induced hepatitis. Israel journal of medical sciences, 28(2), 101-2.
Raveh, D, et al. "Lovastatin-induced hepatitis." Israel journal of medical sciences vol. 28,2 (1992): 101-2.
Raveh D, Arnon R, Israeli A, Eisenberg S. Lovastatin-induced hepatitis. Isr J Med Sci. 1992 Feb;28(2):101-2. PMID: 1559791.
Copy Download .nbib Format: NLM
Fibrillar bodies in hepatocyte nuclei during the course of the toxic hepatitis produced by frog virus 3 in mice.

Journal of ultrastructure research

Bingen A, Kirn A.
PMID: 163907
J Ultrastruct Res. 1975 Feb;50(2):167-73. doi: 10.1016/s0022-5320(75)80047-5.

No abstract available.

Cite
Bingen A, Kirn A. Fibrillar bodies in hepatocyte nuclei during the course of the toxic hepatitis produced by frog virus 3 in mice. J Ultrastruct Res. 1975;50(2):167-73doi: 10.1016/s0022-5320(75)80047-5.
Bingen, A., & Kirn, A. (1975). Fibrillar bodies in hepatocyte nuclei during the course of the toxic hepatitis produced by frog virus 3 in mice. Journal of ultrastructure research, 50(2), 167-73. https://doi.org/10.1016/s0022-5320(75)80047-5
Bingen, A, and Kirn, A. "Fibrillar bodies in hepatocyte nuclei during the course of the toxic hepatitis produced by frog virus 3 in mice." Journal of ultrastructure research vol. 50,2 (1975): 167-73. doi: https://doi.org/10.1016/s0022-5320(75)80047-5
Bingen A, Kirn A. Fibrillar bodies in hepatocyte nuclei during the course of the toxic hepatitis produced by frog virus 3 in mice. J Ultrastruct Res. 1975 Feb;50(2):167-73. doi: 10.1016/s0022-5320(75)80047-5. PMID: 163907.
Copy Download .nbib Format: NLM
Cholestatic hepatitis after administration of furan derivatives.

Archives of internal medicine

Engel JJ, Vogt TR, Wilson DE.
PMID: 150825
Arch Intern Med. 1975 May;135(5):733-5.

A patient developed cholestatic hepatitis while being treated with nitrofurantoin. A second episode of jaundice followed the intravaginal administration of a mixture of furazolidone and nifuroxime. It is important to consider possible cross-sensitivity of chemically related compounds even when...

Cite
Engel JJ, Vogt TR, Wilson DE. Cholestatic hepatitis after administration of furan derivatives. Arch Intern Med. 1975;135(5):733-5
Engel, J. J., Vogt, T. R., & Wilson, D. E. (1975). Cholestatic hepatitis after administration of furan derivatives. Archives of internal medicine, 135(5), 733-5.
Engel, J J, et al. "Cholestatic hepatitis after administration of furan derivatives." Archives of internal medicine vol. 135,5 (1975): 733-5.
Engel JJ, Vogt TR, Wilson DE. Cholestatic hepatitis after administration of furan derivatives. Arch Intern Med. 1975 May;135(5):733-5. PMID: 150825.
Copy Download .nbib Format: NLM
Organic fluorides: implications for psychiatry.

The Journal of clinical psychiatry

Guynn RW, Faillace LA.
PMID: 26669
J Clin Psychiatry. 1978 Jun;39(6):523, 527-31.

The widespread use of synthetic organic fluorides has recently received attention as a potential health hazard. There are a number of organic fluorides which have become important considerations in psychiatry. Therapeutically the organic fluorides include the neuroleptics trifluoperazine, fluphenazine,...

Cite
Guynn RW, Faillace LA. Organic fluorides: implications for psychiatry. J Clin Psychiatry. 1978;39(6):523, 527-31
Guynn, R. W., & Faillace, L. A. (1978). Organic fluorides: implications for psychiatry. The Journal of clinical psychiatry, 39(6), 523, 527-31.
Guynn, R W, and Faillace, L A. "Organic fluorides: implications for psychiatry." The Journal of clinical psychiatry vol. 39,6 (1978): 523, 527-31.
Guynn RW, Faillace LA. Organic fluorides: implications for psychiatry. J Clin Psychiatry. 1978 Jun;39(6):523, 527-31. PMID: 26669.
Copy Download .nbib Format: NLM
Complications of oral contraceptives--a symposium. Liver disease and abnormalities of laboratory tests.

The Western journal of medicine

Fisher DA.
PMID: 162817
West J Med. 1975 Jan;122(1):40-2.
Free PMC Article

No abstract available.

Cite
Fisher DA. Complications of oral contraceptives--a symposium. Liver disease and abnormalities of laboratory tests. West J Med. 1975;122(1):40-2
Fisher, D. A. (1975). Complications of oral contraceptives--a symposium. Liver disease and abnormalities of laboratory tests. The Western journal of medicine, 122(1), 40-2.
Fisher, D A. "Complications of oral contraceptives--a symposium. Liver disease and abnormalities of laboratory tests." The Western journal of medicine vol. 122,1 (1975): 40-2.
Fisher DA. Complications of oral contraceptives--a symposium. Liver disease and abnormalities of laboratory tests. West J Med. 1975 Jan;122(1):40-2. PMID: 162817; PMCID: PMC1130262.
Copy Download .nbib Format: NLM
Erythromycin estolate-induced hepatitis. Ultrastructural study of liver.

New York state journal of medicine

Gafter U, Mandel EM, Weiss S, Djaldetti M.
PMID: 282477
N Y State J Med. 1979 Jan;79(1):87-9.

No abstract available.

Cite
Gafter U, Mandel EM, Weiss S, et al. Erythromycin estolate-induced hepatitis. Ultrastructural study of liver. N Y State J Med. 1979;79(1):87-9
Gafter, U., Mandel, E. M., Weiss, S., & Djaldetti, M. (1979). Erythromycin estolate-induced hepatitis. Ultrastructural study of liver. New York state journal of medicine, 79(1), 87-9.
Gafter, U, et al. "Erythromycin estolate-induced hepatitis. Ultrastructural study of liver." New York state journal of medicine vol. 79,1 (1979): 87-9.
Gafter U, Mandel EM, Weiss S, Djaldetti M. Erythromycin estolate-induced hepatitis. Ultrastructural study of liver. N Y State J Med. 1979 Jan;79(1):87-9. PMID: 282477.
Copy Download .nbib Format: NLM
[Morphometric characteristics of the hepatotoxic effect of ethanol].

Gigiena i sanitariia

Radkevich LA, Pyn'ko NE.
PMID: 2093601
Gig Sanit. 1990 Nov;(11):78-80.

No abstract available.

Cite
Radkevich LA, Pyn'ko NE. Morfometricheskie kharakteristiki gepatotoksicheskogo éffekta étanola. [Morphometric characteristics of the hepatotoxic effect of ethanol]. Gig Sanit. 1990;(11):78-80
Radkevich, L. A., & Pyn'ko, N. E. (1990). Morfometricheskie kharakteristiki gepatotoksicheskogo éffekta étanola. [Morphometric characteristics of the hepatotoxic effect of ethanol]. Gigiena i sanitariia, (11), 78-80.
Radkevich, L A, and Pyn'ko, N E. "Morfometricheskie kharakteristiki gepatotoksicheskogo éffekta étanola." [Morphometric characteristics of the hepatotoxic effect of ethanol]. Gigiena i sanitariia vol. ,11 (1990): 78-80.
Radkevich LA, Pyn'ko NE. Morfometricheskie kharakteristiki gepatotoksicheskogo éffekta étanola. [Morphometric characteristics of the hepatotoxic effect of ethanol]. Gig Sanit. 1990 Nov;(11):78-80. Russian. PMID: 2093601.
Copy Download .nbib Format: NLM
Tuberculosis treatment. Risk, benefit and perspective.

Chest

Glassroth J.
PMID: 1989779
Chest. 1991 Feb;99(2):266-7. doi: 10.1378/chest.99.2.266.

No abstract available.

Cite
Glassroth J. Tuberculosis treatment. Risk, benefit and perspective. Chest. 1991;99(2):266-7doi: 10.1378/chest.99.2.266.
Glassroth, J. (1991). Tuberculosis treatment. Risk, benefit and perspective. Chest, 99(2), 266-7. https://doi.org/10.1378/chest.99.2.266
Glassroth, J. "Tuberculosis treatment. Risk, benefit and perspective." Chest vol. 99,2 (1991): 266-7. doi: https://doi.org/10.1378/chest.99.2.266
Glassroth J. Tuberculosis treatment. Risk, benefit and perspective. Chest. 1991 Feb;99(2):266-7. doi: 10.1378/chest.99.2.266. PMID: 1989779.
Copy Download .nbib Format: NLM
Reappraisal of the health risks associated with the use of high doses of oral and injectable androgenic steroids.

NIDA research monograph

Friedl KE.
PMID: 1964199
NIDA Res Monogr. 1990;102:142-77.

No abstract available.

Cite
Friedl KE. Reappraisal of the health risks associated with the use of high doses of oral and injectable androgenic steroids. NIDA Res Monogr. 1990;102:142-77
Friedl, K. E. (1990). Reappraisal of the health risks associated with the use of high doses of oral and injectable androgenic steroids. NIDA research monograph, 102142-77.
Friedl, K E. "Reappraisal of the health risks associated with the use of high doses of oral and injectable androgenic steroids." NIDA research monograph vol. 102 (1990): 142-77.
Friedl KE. Reappraisal of the health risks associated with the use of high doses of oral and injectable androgenic steroids. NIDA Res Monogr. 1990;102:142-77. PMID: 1964199.
Copy Download .nbib Format: NLM
A case of tubulo-interstitial nephritis with exfoliative dermatitis and hepatitis due to phenobarbital hypersensitivity.

European journal of pediatrics

Sawaishi Y, Komatsu K, Takeda O, Tazawa Y, Takahashi I, Hayasaka K, Takada G.
PMID: 1530819
Eur J Pediatr. 1992 Jan;151(1):69-72. doi: 10.1007/BF02073898.

Severe exfoliative dermatitis and liver dysfunction developed in a 5-year-old girl 3 weeks after initiation of phenobarbital therapy. Liver function improved gradually after discontinuation of phenobarbital. During the convalescent stage an initially mild renal dysfunction was exacerbated by episodes...

Cite
Sawaishi Y, Komatsu K, Takeda O, et al. A case of tubulo-interstitial nephritis with exfoliative dermatitis and hepatitis due to phenobarbital hypersensitivity. Eur J Pediatr. 1992;151(1):69-72doi: 10.1007/BF02073898.
Sawaishi, Y., Komatsu, K., Takeda, O., Tazawa, Y., Takahashi, I., Hayasaka, K., & Takada, G. (1992). A case of tubulo-interstitial nephritis with exfoliative dermatitis and hepatitis due to phenobarbital hypersensitivity. European journal of pediatrics, 151(1), 69-72. https://doi.org/10.1007/BF02073898
Sawaishi, Y, et al. "A case of tubulo-interstitial nephritis with exfoliative dermatitis and hepatitis due to phenobarbital hypersensitivity." European journal of pediatrics vol. 151,1 (1992): 69-72. doi: https://doi.org/10.1007/BF02073898
Sawaishi Y, Komatsu K, Takeda O, Tazawa Y, Takahashi I, Hayasaka K, Takada G. A case of tubulo-interstitial nephritis with exfoliative dermatitis and hepatitis due to phenobarbital hypersensitivity. Eur J Pediatr. 1992 Jan;151(1):69-72. doi: 10.1007/BF02073898. PMID: 1530819.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 10971 entries